HCA Healthcare Reports Prelim Q2 Sales Of ~$20.230B, Up From $18.605B YoY; Lowers FY2026 GAAP EPS From $29.10-$31.50 To $28.70-$30.50
HCA Healthcare, Inc. (NYSE: HCA ) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preliminary financial and operating results are subject to finalization of the Company's quarterly financial and accounting procedures. HCA anticipates revenues in the second qua